The burden for lifestyle diseases such as Diabetes, Hypertension, Dyslipidemia, etc. are increasing worldwide at an alarming rate and the incidence of these diseases are raising very rapidly in developing countries like India. These diseases are the major causes for increasing death rate due to Cardiovascular diseases and stroke. These chronic diseases are perhaps the most challenging health problems for the healthcare system in India.
India leads the world in Diabetes prevalence after China. However, India is anticipated to become the capital for Diabetes with largest diabetic population of around 80 million by 2030 (Ref: WHO report, 2004). Likewise, Hypertension is one of the most important causes of premature death worldwide (WHO report). The overall prevalence for Hypertension in India is 29.8% and raising rapidly day by day. Also, the prevalence of Dyslipidemia is very high in India ranging from 10 – 73%. Dyslipidemia is one of the main causes for Coronary Artery Diseases in people with Diabetes & Hypertension. The inter-relationship of co-existence of these lifestyle diseases have been shown by various epidemiological studies. Therefore, new researches & biotechnological developments in the last decade have lead to the advancement of new drugs for lifestyle diseases management.
Diabetology & Cardiovascular are one of the fastest growing segments in the domestic market. In perspective of the huge market potential of Cardio-diabetic segment, Diacarex HealthCare division was established in April 2016, intended to offer drugs for the management of chronic lifestyle diseases such as Diabetes, Hypertension, Dyslipidemia and other co-morbid conditions. Thus, Diacarex HealthCare operates majorly in Cardiology and Diabetology therapeutic segments, one of the leading therapeutic segments in the country.
The division has been initially launched in Tamilnadu with 11 products; majorly include Anti-Diabetic drugs followed by Anti-hypertensive, Anti-lipidemic & Anti-neuropathic drugs. The areas and product range shall be extended in near future. Our brands are forayed into the market to offer quality & cost-effective healthcare to the community. Diacarex is poised to grow very fast and develop as the most significant division of Dermarex HealthCare.